首页 > 专家库
朱君荣

领域:生物产业 学校:中国药科大学职称:主任药师

专业方向为临床药学与药事管理,近年来主要致力于药物个体化治疗研究及临床药学照护平台建设,包括心血管药物、抗肿瘤药物、抗感染药物及高风险药物的药物遗传学研究、药代动力学系统理论与药物临床药效和不良反应间的关联性研究、个体化给药模型的建模研究...

具体了解该专家信息,请致电:027-87555799 邮箱 haizhi@uipplus.com

教育背景

工作经历

项目课题经历

论文、成果、著作等

Junrong Zhu(通讯作者),The development of an individualized warfarin dose algorithm based on a population pharmacokinetic model to improve prediction accuracy for Chinese patients after heart valve replacement.Acta PharmacologicaSinica 2017(38):434-442(IF3.223)

2、Qin Zhao, Feng Yu,Junrong Zhu(通讯作者),et al.A algorithm to predict tramadol response from polymorphisms of CYP2D6, p-gp, OPRM1, COMT and psychological factors: Derivation in Han Chinese patients undergoing upper limb fracture internal-fixation surgery.Pharmacogenomics,2014 15(4),487-495 ( IF3.425)

3、Meng Wei,YuBing Zhu,Junrong Zhu(通讯作者),et al. .A new algorithm to predict warfarin dose from polymorphisms of CYP4F2, CYP2C9 and VKORC1 and clinical variables: Derivation in Han Chinese patients with non valvular atrial fibrillation.Thromb Haemost, 2012; 107/6. ( IF6.081)

4、Jun-rong ZHU(第一作者),Yi-fu TAO,Shen LOU,et al.Protective effects of ginsenoside Rb3 on oxygen and glucose deprivation-induced ischemic injury in PC12 cells. Acta Pharmacologica Sinica, 2010,31: 273–280 ( IF 2.354)

专利、著作版权等

声明:本站专家信息来源于各高校官网。